Search results
Results from the WOW.Com Content Network
Sulfamethoxazole (SMZ or SMX) is an antibiotic. It is used for bacterial infections such as urinary tract infections, bronchitis, and prostatitis and is effective against both gram negative and positive bacteria such as Escherichia coli and Listeria monocytogenes. [1] Common side effects include nausea, vomiting, loss of appetite, and skin rashes.
Demeclocycline is officially indicated for the treatment of various types of bacterial infections. [3] It is used as an antibiotic in the treatment of Lyme disease, [4] acne, [5] and bronchitis. [6] Resistance, though, is gradually becoming more common, [7] and demeclocycline is now rarely used for treatment of infections. [8] [9]
Rates of side effects appear to be higher than some groups of antibiotics such as cephalosporins but lower than others such as clindamycin. [7] Studies in other animals raise concerns regarding use in pregnancy. [8] No problems were identified, however, in the children of a small number of women who took the medication. [8]
Two separate patients who were prescribed a popular class of antibiotic told WFTS the drug came with severe side effects. For both women, the family of antibiotics known as fluoroquinolones ...
Cefazolin, also known as cefazoline and cephazolin, is a first-generation cephalosporin antibiotic used for the treatment of a number of bacterial infections. [2] Specifically it is used to treat cellulitis, urinary tract infections, pneumonia, endocarditis, joint infection, and biliary tract infections. [2]
Common side effects are diarrhoea (in 5% of people receiving ertapenem), nausea (in 3%) and vomiting, reactions at the injection site (5%, including pain and inflammation of the vein), and headache. Uncommon but possibly serious side effects include candida infections , seizures , skin reactions such as rashes (including nappy rash in children ...
It is one of the few drugs commonly used in pregnancy to treat UTIs. [38] There is a potential risk of hemolytic anemia in the newborn when used near time of delivery. [3] Newborns of women given this drug late in pregnancy had a higher risk of developing neonatal jaundice. [39] Evidence of safety in early pregnancy is mixed as of 2017. [40]
These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, [29] but gynecomastia is generally reported to occur in 70 to 80% of patients. [30] In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide ...